Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2026-01-04 @ 3:04 PM
Study NCT ID:
NCT05936359
Status:
RECRUITING
Last Update Posted:
2025-11-18
First Post:
2023-06-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-25
Start Date Type:
ACTUAL
Primary Completion Date:
2028-02-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02-29
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-21
First Submit QC Date:
None
Study First Post Date:
2023-07-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-17
Last Update Post Date:
2025-11-18
Last Update Post Date Type:
ESTIMATED